Ravi Rajagopal resigns as Fortis Healthcare chairman

Published On 2024-08-08 11:45 GMT   |   Update On 2024-08-08 11:45 GMT

Bengaluru: Fortis Healthcare has announced that its Chairman and Non-Executive Independent Director, Ravi Rajagopal is resigning from his directorship with the company.

Rajagopal cited his "expanded board commitments in the UK and other regions" as the reason for his departure. He will also step down from his role on the company’s Corporate Social Responsibility Committee.  

Rajagopal will also cease to be a member of the company's Corporate Social Responsibility Committee, it added.

His departure will be effective Sept 30.

Also Read:GMCH Superintendent refutes Doctors' mass resignation claims, Assam CM shares data

According to Reuters, Rajagopal was appointed as chairman in June 2018, at a time when the private hospital chain was facing mounting debts and a regulatory probe.

In his resignation letter, Rajagopal said from the time the Group faced various challenges to its current trajectory of sustained performance, it has been a personally fulfilling experience.

The company cited his expanded board commitments, in the UK and other regions, in its exchange filing on Tuesday. 

According to the Financial Express report, “The Company further wish to mention that consequent to his resignation as Chairman of Board and Non- Executive Independent Director, Mr Ravi Rajagopal ceases to be a member of Corporate Social Responsibility Committee of the Company,” it stated.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News